Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Basilea Rises Most in 11 Months on Takeover Speculation
Bloomberg
Thursday, January 6, 2011 - 8:02am
tags:
Basilea, M&A
The World's Most-Watched Pharma
Motley Fool
Thursday, January 6, 2011 - 8:01am
tags:
JNJ, Pfizer, Abbott Laboratories, Merck, Teva Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly
Inspire Pharmaceuticals: Looking for Inspiration Following Denufosol Failure
Seeking Alpha
Thursday, January 6, 2011 - 7:43am
tags:
Inspire, denufosol, cystic fibrosis
Why Cerus Is My Stock of the Year
Motley Fool
Thursday, January 6, 2011 - 7:42am
tags:
Cerus
Merck Ends Drug Research Pact With Ranbaxy, Economic Times Says
Bloomberg
Thursday, January 6, 2011 - 7:41am
tags:
Merck, Ranbaxy
Spectrum Pharma Jumps in With the Big Dogs
Motley Fool
Thursday, January 6, 2011 - 7:40am
tags:
Spectrum Pharmaceuticals, Roche, biosimilars, Biogen Idec, Rituxan
Roche Wins Broader U.S. Approval for Actemra Arthritis Drug
Bloomberg
Thursday, January 6, 2011 - 7:39am
tags:
Actemra, Roche, arthritis
Does United Therapeutics Miss the Grade?
Motley Fool
Thursday, January 6, 2011 - 7:33am
tags:
United Therapeutics, Teva Pharmaceuticals, GSK, Pfizer
A Pregnant Pause Over A Merck Contraceptive
Pharmalot
Wednesday, January 5, 2011 - 12:12pm
tags:
Merck, Implanon, UK, contraceptives
Birmingham court to oversee nearly 1200 Pfizer lawsuits over Chantix
Birmingham News, AL
Wednesday, January 5, 2011 - 11:51am
tags:
Alabama, Pfizer, Chantix, lawsuits, smoking cessation
Mann doubles down on biotech as Afrezza decision looms
Fierce Biotech
Wednesday, January 5, 2011 - 11:49am
tags:
diabetes, MannKind, inhaled insulin, Afrezza
Will hedge funds back pharma whistleblowers?
Fierce Pharma
Wednesday, January 5, 2011 - 11:44am
tags:
hedge funds, whistleblowers, GSK
Avastin raises heart failure risk in breast cancer
Reuters
Wednesday, January 5, 2011 - 11:43am
tags:
Roche, Avastin, heart failure, breast cancer
Drug indexes dip; Sinovac falls on downgrade
Marketwatch
Wednesday, January 5, 2011 - 11:42am
tags:
Sinovac, drug stocks
Will the Neudexta Launch Transform Avanir Into a Mature Biotech?
Seeking Alpha
Wednesday, January 5, 2011 - 11:42am
tags:
Neudexta, Avanir, PBA
Opexa soars on talks with FDA over MS drug
Marketwatch
Wednesday, January 5, 2011 - 11:10am
tags:
FDA, MS, Opexa, multiple sclerosis, Tovaxin
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wednesday, January 5, 2011 - 11:09am
tags:
biotech, Celgene, Dendreon, MannKind, Vertex Pharmaceuticals, Genzyme, Ariad Pharmaceuticals, Keryx
There Were Fewer Pharma Job Cuts In 2010
Pharmalot
Wednesday, January 5, 2011 - 11:05am
tags:
layoffs
UCB Expects to Exceed Guidance for 2010 Revenue, Earnings
Bloomberg
Wednesday, January 5, 2011 - 11:04am
tags:
UCB Pharmaceuticals, guidance
Lesson From Gilead: Don’t Describe Your Drugs as “Dope”
BNET Pharma
Wednesday, January 5, 2011 - 11:03am
tags:
Gilead Sciences, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.